Difference between revisions of "Biomod/2013/OSU/resources"

From OpenWetWare
Jump to: navigation, search
(New page: {{OhioMOD2013}} <html> <h1>Resources</h1> <center> <a href="http://openwetware.org/wiki/Biomod/2013/OSU/results/concentrations">Concentrations</a> </center> </div> </html> [http://ope...)
 
 
(3 intermediate revisions by the same user not shown)
Line 2: Line 2:
  
 
<html>
 
<html>
 +
<head>
 +
<style type="text/css">
  
 +
.sources li{
 +
padding-bottom: 10px;
 +
}
 +
 +
</style>
 +
</head>
 +
 +
 +
<div id="resources-content" style="width:65%;margin-left:auto;margin-right:auto;">
 
<h1>Resources</h1>
 
<h1>Resources</h1>
<center>
+
<ol class="sources">
 +
<li>Zhao YX, Shaw A, Zeng X, Benson E, Nyström AM, Högberg B. DNA origami delivery system for cancer therapy with tunable release properties. ACS Nano. 2012 Oct 23;6(10):8684-91. doi: 10.1021/nn3022662. Epub 2012 Sep 13. PubMed PMID: 22950811.</li>
 +
<li>Jiang Q, Song C, Nangreave J, Liu X, Lin L, Qiu D, Wang ZG, Zou G, Liang X, Yan H, Ding B. DNA origami as a carrier for circumvention of drug resistance. J Am Chem Soc. 2012 Aug 15;134(32):13396-403. doi: 10.1021/ja304263n. Epub 2012 Aug 1. PubMed PMID: 22803823.</li>
 +
<li>Skribek H, Otvos R, Flaberg E, Nagy N, Markasz L, Eksborg S, Masszi T, Kozma A, Adam E, Miseta A, Klein E, Szekely L. Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin. Exp Hematol. 2010 Dec;38(12):1219-30. doi: 10.1016/j.exphem.2010.09.001. Epub 2010 Sep 15. PubMed PMID: 20837094.</li>
 +
<li>Aubel-Sadron G, Londos-Gagliardi D. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review. Biochimie. 1984 May;66(5):333-52. Review. PubMed PMID: 6380596.</li>
 +
<li>Ashley et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported bilayers. Nature Materials: 10, 2011.</li>
 +
<li>Aubel-Sadron G et al. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review. Biochimie 66: 333-52, 1984. </li>
 +
<li>Douglas et al. A logic-gated nanorobot for targeted transport of molecular payloads. Science. 335, 2012.</li>
 +
<li>Frederick, C et al. Structural comparison of anticancer drug-DNA complexes: Adriamycin and daunomycin. Biochemistry 29: 2538-2549, 1990.</li>
 +
<li>Gallagher A et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54(3):713-33, 1979</li>
 +
<li>Gottesman, M. Mechanisms of cancer drug resistance. Ann. Rev. Med 53: 615-27, 2002.</li>
 +
<li>Houee-Levin C et al. One-electorn reduction of daunorubicin intercalated in DNA or in A protein: A radiolysis study. Free Radical Research 11(5): 251-60, 1990. </li>
 +
<li>Jiang Q et al. DNA origami as a carrier for circumvention of drug resistance. J Am Chem Soc 134(32): 13396-403, 2012.
 +
<li>Legrand O et al. Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in-vivo resistance in adult acute myeloid leukemia. Blood 94(3): 1046-56, 1999.</li>
 +
<li>Li J et al.  Self-Assembled Multivalent DNA Nanostructures for Noninvasive Intracellular Delivery of Immunostimulatory CpG Oligonucleotides. ACS Nano 5(11):8781-789, 2011. </li>
 +
<li>Ma D et al. Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia. BR J Cancer 70(2):324-32, 1994. </li>
 +
<li>Ma P et al. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. J Biomed nanotechnology 5(2):151-61, 2009.</li>
 +
<li>Mei Q et al. Stability of DNA origami nanoarrays in cell lysate. Nano Lett 11(4): 1477-82, 2011.
 +
<li>Meng H et al. Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. ACS Nano 5(6); 4434-47, 2011.</li>
 +
<li>Pigram W et al. Sterochemistyr of intercalation: interaction of daunomycin with DNA. Nature New Biology 235: 17-19, 1972.
 +
<li>Reichle A et al. Chemomodulation of drugs involved in multidrug resitance in chronic lymphatic leukemia of the B-cell type. Cancer Chemother Pharmacol. 34(4): 307-16, 1999.</li>
 +
<li>Schuller VJ, Cellular immunostimulation by CpG-sequence-coated DNA origami structures. ACS Nano 5(12):9696-702, 2011
 +
<li>Skribek H et al. Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin. Exp. Hematology 38: 1219-1230, 2010. </li>
 +
<li>Svoboda-Beusan I et al. The relevance of multidrug resistance-associated P-glycoprotein expression in the treatment response of B-cell chronic lymphocytic leukemia. Haematolgica 85: 1261-67, 2000.</li>
 +
<li>Wang A et al. Nanoparticle delivery of cancer drugs. Annu. Rev. Med. 63:185-98, 2012.</li>
 +
 
  
<a href="http://openwetware.org/wiki/Biomod/2013/OSU/results/concentrations">Concentrations</a>
+
</ol>
</center>
 
  
 
</div>
 
</div>
  
 
</html>
 
</html>
[http://openwetware.org/index.php?title=Biomod/2013/OSU/resources&action=edit Edit]
 
  
 
{{OSUFooter}}
 
{{OSUFooter}}

Latest revision as of 07:31, 26 October 2013


<html> </div> </div> </div> <head> <style type='text/css'>

.firstHeading, #column-one, #p-bookmarks, #p-history , .portlet{ display:none; }

  1. bodyContent, #content{

display:none; background-color:#FFFFFF;

}

  1. column-content, .container, #globalWrapper, body{

background-color:#FFFFFF; }

p{ color:dimgrey; text-align:center; margin-left:auto; margin-right:auto; font-gamily:Calibri; font-size: 15px; }

.selflink{ display: table-cell;

  text-decoration: none;
  font-family: Gill Sans MT;
  outline: none;
  font-size: 20px;
  color: dimgrey;
  border-right: 2px solid dimgray;
  padding: 15px 25px; /* sets button size */
  font-weight:normal;

}

ul.navigation-bar {

  list-style-type: none;
  border: 2px solid dimgray;
  padding: 0px;
  margin-left: 20px;

width:615px;

  *line-height: 3.2em; /* IE6,IE7 */
  }

ul.navigation-bar li {

  display: table-cell;
  background-image: -webkit-linear-gradient(bottom, silver, azure);
  background-image:    -moz-linear-gradient(bottom, silver, azure);
  background-image:     -ms-linear-gradient(bottom, silver, azure);
  background-image:         linear-gradient(bottom, silver, azure);
  background-color: midnightblue; /* IE6...IE9 */
  *display: inline; /* IE6,IE7 */
  }


ul.navigation-bar li:hover {

  background-image: -webkit-linear-gradient(top, silver, azure);
  background-image:    -moz-linear-gradient(top, silver, azure);
  background-image:     -ms-linear-gradient(top, silver, azure);
  background-image:         linear-gradient(top, silver, azure);

}

ul.navigation-bar li a, ul.navigation-bar li ul li a {

  display: table-cell;
  text-decoration: none;
  font-family: Gill Sans MT;
  outline: none;
  font-size: 20px;
  color: dimgrey;
  border-right: 0px;
  padding: 15px 25px; /* sets button size */
  }

ul.navigation-bar li ul{ list-style: none; display: none; position: absolute; padding: 0px; margin: 1px 0px 0px -1px; background-color:#FFFFFF; border: 1px solid dimgrey; z-index:5; } ul.navigation-bar li ul li{ background-image: none; background-color:#FFFFFF; border-right: none; border: 0px solid dimgray; display: block; float: none; position: relative; }

ul.navigation-bar li ul li:hover{ background-image:none; background-color: lightgrey; }

ul.navigation-bar li:hover ul{ list-style: none; display: block; position: absolute; }

ul.navigation-bar li a{ display: block; }

.profile-right{ clear:both; }

.profile-right p{ text-align:left; float: left; } .profile-right img{ float: right; padding: 20px; }

.profile-left{ clear:both; }

.profile-left p{ text-align:left; float:left; }

.profile-left img{ float: left; padding:20px; }

  1. OSUfooter{

clear:both; }


  1. protocol-content table td{

border: 1px solid black; text-align:center; }

  1. protocol-content p{

text-align:left; }

.overlay-bg{ display:none; position:fixed; top:0; left:0; height:100%; width:100%; cursor: pointer; background: #000; background: rgba(0,0,0,0.75); }

.overlay-content{ background:#fff; padding:1%; width: 60%; position: relative; top:15%; left:50%; margin: 0 0 0 -30%; cursor: default; -webkit-border-radius: 5px; -moz-border-radius: 5px; border-radius: 5px; box-shadow: 0 0 5px rgba(0,0,0,0.9);

}

.close-btn{ float:right; font-size:x-large; margin-top:-10px; }

</style>


<script src="//ajax.googleapis.com/ajax/libs/jquery/1.10.1/jquery.min.js"></script>

<script type="text/javascript"> $(document).ready(function() {

 $('.show-popup').click(function(event){
 event.preventDefault();
 $('.overlay-bg').show();

});

$('.close-btn').click(function(){ $('.overlay-bg').hide(); });

$('.overlay-bg').click(function(){

 $('.overlay-bg').hide();

});

$('.overlay-content').click(function(){ return false; });

}); </script>

</head>

<!-- navbar -->

<a href="http://openwetware.org/wiki/Biomod/2013"> << Back to Team Pages</a>

<center>

<img src="http://openwetware.org/images/1/15/Ohiomod2013.jpg" height="60%" width="60%" style="margin-left:-40px;"> <div id="navbar" style="margin-left:auto; margin-right:auto;text-align:center;width:650px;height:auto;" > <ul id="homebutton" class="navigation-bar"> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU">Home</a></li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/about">About</a> <ul> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/abstract">Abstract</a></li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/goals">Goals</a></li>

<li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/about">Description</a> </ul> </li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/experiments">Project</a> <ul> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/experiments">Life of Project</a></li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/protocol">Protocols</a></li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/labnotes">Lab Notes</a></li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/meetingnotes">Meeting Notes</a></li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/resources">Resources</a></li> </ul> </li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/results">Results</a> <ul> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/results">Experimental Results</a></li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/data">Data</a></li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/futurework">Future Work</a></li> </li> </ul> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/media">Media</a> <ul> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/projectvideo">Project Video</a><li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/animations">Animations</a><li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/videoblogs">Video Blog</a></li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/photos">Photos</a></li> </ul> </li> <li><a href="http://openwetware.org/wiki/Biomod/2013/OSU/team">Team</a></li> </ul>

</div>

</center> </html>

<html> <head> <style type="text/css">

.sources li{ padding-bottom: 10px; }

</style> </head>


<div id="resources-content" style="width:65%;margin-left:auto;margin-right:auto;"> <h1>Resources</h1> <ol class="sources"> <li>Zhao YX, Shaw A, Zeng X, Benson E, Nyström AM, Högberg B. DNA origami delivery system for cancer therapy with tunable release properties. ACS Nano. 2012 Oct 23;6(10):8684-91. doi: 10.1021/nn3022662. Epub 2012 Sep 13. PubMed PMID: 22950811.</li> <li>Jiang Q, Song C, Nangreave J, Liu X, Lin L, Qiu D, Wang ZG, Zou G, Liang X, Yan H, Ding B. DNA origami as a carrier for circumvention of drug resistance. J Am Chem Soc. 2012 Aug 15;134(32):13396-403. doi: 10.1021/ja304263n. Epub 2012 Aug 1. PubMed PMID: 22803823.</li> <li>Skribek H, Otvos R, Flaberg E, Nagy N, Markasz L, Eksborg S, Masszi T, Kozma A, Adam E, Miseta A, Klein E, Szekely L. Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin. Exp Hematol. 2010 Dec;38(12):1219-30. doi: 10.1016/j.exphem.2010.09.001. Epub 2010 Sep 15. PubMed PMID: 20837094.</li> <li>Aubel-Sadron G, Londos-Gagliardi D. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review. Biochimie. 1984 May;66(5):333-52. Review. PubMed PMID: 6380596.</li> <li>Ashley et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported bilayers. Nature Materials: 10, 2011.</li> <li>Aubel-Sadron G et al. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review. Biochimie 66: 333-52, 1984. </li> <li>Douglas et al. A logic-gated nanorobot for targeted transport of molecular payloads. Science. 335, 2012.</li> <li>Frederick, C et al. Structural comparison of anticancer drug-DNA complexes: Adriamycin and daunomycin. Biochemistry 29: 2538-2549, 1990.</li> <li>Gallagher A et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54(3):713-33, 1979</li> <li>Gottesman, M. Mechanisms of cancer drug resistance. Ann. Rev. Med 53: 615-27, 2002.</li> <li>Houee-Levin C et al. One-electorn reduction of daunorubicin intercalated in DNA or in A protein: A radiolysis study. Free Radical Research 11(5): 251-60, 1990. </li> <li>Jiang Q et al. DNA origami as a carrier for circumvention of drug resistance. J Am Chem Soc 134(32): 13396-403, 2012. <li>Legrand O et al. Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in-vivo resistance in adult acute myeloid leukemia. Blood 94(3): 1046-56, 1999.</li> <li>Li J et al. Self-Assembled Multivalent DNA Nanostructures for Noninvasive Intracellular Delivery of Immunostimulatory CpG Oligonucleotides. ACS Nano 5(11):8781-789, 2011. </li> <li>Ma D et al. Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia. BR J Cancer 70(2):324-32, 1994. </li> <li>Ma P et al. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. J Biomed nanotechnology 5(2):151-61, 2009.</li> <li>Mei Q et al. Stability of DNA origami nanoarrays in cell lysate. Nano Lett 11(4): 1477-82, 2011. <li>Meng H et al. Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. ACS Nano 5(6); 4434-47, 2011.</li> <li>Pigram W et al. Sterochemistyr of intercalation: interaction of daunomycin with DNA. Nature New Biology 235: 17-19, 1972. <li>Reichle A et al. Chemomodulation of drugs involved in multidrug resitance in chronic lymphatic leukemia of the B-cell type. Cancer Chemother Pharmacol. 34(4): 307-16, 1999.</li> <li>Schuller VJ, Cellular immunostimulation by CpG-sequence-coated DNA origami structures. ACS Nano 5(12):9696-702, 2011 <li>Skribek H et al. Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin. Exp. Hematology 38: 1219-1230, 2010. </li> <li>Svoboda-Beusan I et al. The relevance of multidrug resistance-associated P-glycoprotein expression in the treatment response of B-cell chronic lymphocytic leukemia. Haematolgica 85: 1261-67, 2000.</li> <li>Wang A et al. Nanoparticle delivery of cancer drugs. Annu. Rev. Med. 63:185-98, 2012.</li>


</ol>

</div>

</html>


<html>

<head> <style>

  1. Footer table {
  width: 96.8%;
  max-width:2350px;
  bottom:0px;
  height:50px;   /* Height of the footer */
  font-weight:300;
  background-color: #2E2E2E;
   text-align:center;
   color: white;
   font-size:13px;
   border: 3px white solid; 

}

  1. Footer {
   clear: both; /*may be omitted*/
   position: absolute;
   bottom: 12px; 
   background-color:#fffff;
   width: 100%;
   height: 40px; /* or anything you like */
}


</style> </head> <div id="Footer" >

       <table>
           <tr>

<td id="osuicon" align="left"><a href="http://www.osu.edu" target="_blank"><img src="http://openwetware.org/images/c/cd/TheOhioStateUniversity-REV-Horiz-RGBHEX.png"height="30" width="190" /></td>

<td id="email">Contact us at <a href="mailto:theohiomod@gmail.com"><font color="white">theohiomod@gmail.com</a></td>

<td id="nblicon"><a href="http://mae.osu.edu/labs/nbl/"target="_blank"><img src="http://openwetware.org/images/e/e9/NBL_logo-RGBHEX.png"height="40" width="40"/></td>

<td id="fbicon"><a href="http://www.facebook.com/OhioMod?fref=photo"target="_blank"><img src="http://openwetware.org/images/3/3f/Facebook_icon.png"height="40" width="40"/></td>

           </tr>
       </table>
   </div>

</html>